Fresenius SE & Co. KGaA

BUL:FRE Stock Report

Market Cap: €14.6b

Fresenius SE KGaA Valuation

Is FRE undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of FRE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: FRE (€28.82) is trading below our estimate of fair value (€91.99)

Significantly Below Fair Value: FRE is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for FRE?

Key metric: As FRE is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for FRE. This is calculated by dividing FRE's market cap by their current earnings.
What is FRE's PE Ratio?
PE Ratio15.5x
Earnings€941.00m
Market Cap€14.62b

Price to Earnings Ratio vs Peers

How does FRE's PE Ratio compare to its peers?

The above table shows the PE ratio for FRE vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average25.3x
FME Fresenius Medical Care
18.6x19.3%€12.3b
DVA DaVita
15.9x4.3%US$13.1b
DGX Quest Diagnostics
21.4x11.7%US$17.9b
LH Labcorp Holdings
45.2x20.5%US$19.7b
FRE Fresenius SE KGaA
15.5x20.8%€14.6b

Price-To-Earnings vs Peers: FRE is good value based on its Price-To-Earnings Ratio (15.5x) compared to the peer average (25.3x).

Price to Earnings Ratio vs Industry

How does FRE's PE Ratio compare vs other companies in the European Healthcare Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
FRE 15.5xIndustry Avg. 18.2xNo. of Companies9PE01020304050+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: FRE is good value based on its Price-To-Earnings Ratio (15.5x) compared to the European Healthcare industry average (17.7x).

Price to Earnings Ratio vs Fair Ratio

What is FRE's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

FRE PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio15.5x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate FRE's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Siemens Healthineers

€54.9b

Through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide.

SHL

€48.44

7D

0%

1Y

n/a

Etropal AD

лв20.5m

Engages in the research, development, and manufacture of disposable medical devices for dialysis in Bulgaria.

ETR

лв4.10

7D

0%

1Y

-14.6%